Whole-blood interferon-γ assay for the diagnosis of tuberculosis infection in an unselected Greek population

Respirology

Volumn 13, Issue 2, 2008, Pages 270-274

  Gerogianni, Irini ^a   Papala, Maria ^a   Klapsa, Dimitra ^a   Zinzaras, Elias ^a   Petinaki, Efi ^a   Gourgoulianis, K I ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Diagnosis; Immunosuppression; Interferon ; Tuberculosis

Indexed keywords

GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; FEMALE; GREECE; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULIN TEST; UNIVARIATE ANALYSIS;

ADULT; AGED; BCG VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 40749085212     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01188.x     Document Type: Article

References (24)

1. World Health Organization. Global Tuberculosis Control: Surveillance Planning, Financing. WHO Report 2004. WHO, Geneva, Switzerland.
2. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992 257 : 1055 64.
3. Advisory Council for the Elimination of Tuberculosis (ACET). Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm. Rep. 1999 48 : 1 13.
4. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin. Infect. Dis. 1993 17 : 968 75.
5. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immunobased diagnosis of tuberculosis. Lancet 2000 356 : 1099 104.
6. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001 357 : 2017 21.
7. Cellestis Ltd. Quantiferon Gold Package Insert. Cat. No. 05990201. Victoria, Australia, 2005. Available from URL: http://www.cellestis.com
8. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y et al. Specific detection of tuberculosis infection: an interferon γ-based assay using new antigens. Am. J. Respir. Crit. Care Med. 2004 170 : 59 64.
9. Kang YA, Lee HW, Yoon HI, Cho BL, Han SK et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis in an intermediate tuberculosis-burden country. JAMA 2005 293 : 2756 61.
10. World Health Organization. Tuberculosis Report 2005. [Accessed April 2006.] Available from URL: http://www.who.International/tb
11. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med. 2004 170 : 65 9.
12. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 2000 161 : S221 47.
13. Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P et al. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect. Immun. 2004 72 : 2574 81.
14. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment. Clin. Infect. Dis. 2004 38 : 757 9.
15. Godgkin AJ, Thomas HC, Openshaw PJ. Evolution of epitope-specific memory CD4 (+) T cells after clearance of hepatitis C virus. J. Immunol. 2002 169 : 2210 14.
16. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003 361 : 1168 73.
17. Mahomed H, Hughes EJ, Hawkrige T, Minnies D, Simon E et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int. J. Tuberc. Lung Dis. 2006 10 : 310 16.
18. Mori T. Recent trends in tuberculosis. Japan. Emerg. Infect. Dis. 2000 6 : 566 8.
19. Uplekar MW, Rangan S, Weiss MG, Ogden J, Borgdorff MW et al. Attention to gender issues in tuberculosis control. Int. J. Tuberc. Lung Dis. 2001 5 : 220 4.
20. von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Wadell R et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int. J. Tuberc. Lung Dis. 2001 5 : 1122 8.
21. Barnes PF. Diagnosing latent tuberculosis infection: the 100-year up-grade. Am. J. Respir. Crit. Care Med. 2001 163 : 807 8.
22. Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to gold. Am. J. Respir. Crit. Care Med. 2004 170 : 5 6.
23. Dascalopoulos GA, Loukas S, Constantopoulos SH. Wide geographic variations of sensitivity to MOTT sensitins in Greece. Eur. Respir. J. 1995 5 : 715 17.
24. Gitti Z, Neonakis I, Fanti G, Kontos F, Maraki S et al. Use of the GenoType Mycobacterium CM and AS assays to analyze 76 nontuberculous mycobacterial isolates from Greece. J. Clin. Microbiol. 2006 44 : 2244 6.